Costanera, Hepolito F.

HRN: 14-01-05  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2024
CO-AMOXICLAV 625MG (TAB)
04/26/2024
05/02/2024
PO
625mg
TID
Soft Tissue Infection
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: